References

  1.      Scheinman JI: Sickle cell nephropathy. In: Pediatric Nephrology,edited by Holliday M, Barratt TM, Avner ED, Baltimore, Williams & Wilkins. 1994; 908–919.

2.      Powars DR, Elliot-Mills DD, Chan L, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 1991; 115: 614–620.

3.      Platt RS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. N Engl J Med 1994; 330: 1639–1644.

4.      Scheinman JI.  Sickle cell disease and the kidney. Nat Clin Pract Nephrol 2009; 5:78-88.

5.      Silva Junior GB, Libório AB, Daher EF: New insights on pathophysiology, clinical manifestations, diagnosis,and treatment of sickle cell nephropathy. Ann Hematol 2011;90:1371-1379.

6.      Sharpe CC, Thein SL: Sickle cell nephropathy – a practical approach. Br J Haematol 2011; 155:287-297.

7.      de Jong PE, Statius van Eps LW. Sickle cell nephropathy: new insights into its pathophysiology.  Kidney Int. 1985; 27:711–717.

8.      Allon M. Renal abnormalities in sickle cell disease. Arch. Intern. Med. 1990; 150:501–504.

9.      Maurel S, et al. Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease. Clin. J. Am. Soc. Nephrol. 2014; 9:648–653.  

10.  DeFronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR. Impaired renal tubular potassium secretion in sickle cell disease. Ann. Intern. Med. 1979; 90:310–316.

11.  Batlle D, Itsarayoungyuen K, Arruda JA, Kurtzman NA. Hyperkalemic hyperchl-oremic metabolic acidosis in sickle cell hemoglobinopathies. Am. J. Med. 1982; 72:188–192. 

Corresponding Author

Jahnabi Bhagawati

Resident, Dept. of Medicine, DMIMS Univ.,

JN Medical College, Sawangi (M), Wardha- 442004 Maharashtra